These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19240183)

  • 1. DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer.
    D'Antonio JM; Vander Griend DJ; Isaacs JT
    Endocr Relat Cancer; 2009 Jun; 16(2):325-32. PubMed ID: 19240183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.
    Litvinov IV; Vander Griend DJ; Antony L; Dalrymple S; De Marzo AM; Drake CG; Isaacs JT
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15085-90. PubMed ID: 17015840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.
    Vander Griend DJ; Litvinov IV; Isaacs JT
    Int J Biol Sci; 2014; 10(6):627-42. PubMed ID: 24948876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation.
    Vander Griend DJ; Litvinov IV; Isaacs JT
    Cell Cycle; 2007 Mar; 6(6):647-51. PubMed ID: 17387277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of androgen receptor in progression of LNCaP prostate cancer cells from G1 to S phase.
    Murthy S; Wu M; Bai VU; Hou Z; Menon M; Barrack ER; Kim SH; Reddy GP
    PLoS One; 2013; 8(2):e56692. PubMed ID: 23437213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of androgen receptor in prostate cancer cell cycle regulation: interaction with cell cycle regulatory proteins and enzymes of DNA synthesis.
    Sivanandam A; Murthy S; Kim SH; Barrack ER; Veer Reddy GP
    Curr Protein Pept Sci; 2010 Sep; 11(6):451-8. PubMed ID: 20491624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.
    Jin F; Fondell JD
    Nucleic Acids Res; 2009 Aug; 37(14):4826-38. PubMed ID: 19520769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.
    Fleyshman D; Cheney P; Ströse A; Mudambi S; Safina A; Commane M; Purmal A; Morgan K; Wang NJ; Gray J; Spellman PT; Issaeva N; Gurova K
    Cell Cycle; 2016; 15(3):455-70. PubMed ID: 26694952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein.
    Gao S; Gao Y; He HH; Han D; Han W; Avery A; Macoska JA; Liu X; Chen S; Ma F; Chen S; Balk SP; Cai C
    Cell Rep; 2016 Oct; 17(4):966-976. PubMed ID: 27760327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity.
    Wang J; Zhang H; Zhang X; Wang P; Wang H; Huang F; Zhou C; Zhou J; Li S
    Oncotarget; 2016 Dec; 7(49):81377-81388. PubMed ID: 27835608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor.
    Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S
    J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.
    Li D; Tian G; Wang J; Zhao LY; Co O; Underill ZC; Mymryk JS; Claessens F; Dehm SM; Daaka Y; Liao D
    Prostate; 2018 Nov; 78(15):1140-1156. PubMed ID: 30009471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.
    Shah S; Hess-Wilson JK; Webb S; Daly H; Godoy-Tundidor S; Kim J; Boldison J; Daaka Y; Knudsen KE
    Mol Cancer Res; 2008 Sep; 6(9):1507-20. PubMed ID: 18819937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
    Vander Griend DJ; D'Antonio J; Gurel B; Antony L; Demarzo AM; Isaacs JT
    Prostate; 2010 Jan; 70(1):90-9. PubMed ID: 19790235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
    Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
    Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
    Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.